Osteocalcin concentrations in plasma prepared with different anticoagulants

1991 ◽  
Vol 37 (2) ◽  
pp. 281-284 ◽  
Author(s):  
Michael J Power ◽  
Bernadette O'Dwyer ◽  
Eugene Breen ◽  
Patrick F Fottrell
Keyword(s):  
Enzyme Immunoassay ◽  
Sodium Citrate ◽  
Serum Osteocalcin ◽  
Plasma Samples ◽  
Serum Samples ◽  
Blood Samples ◽  
Freeze Thaw ◽  
Significant Difference

Abstract We investigated the effects on plasma osteocalcin concentrations of different anticoagulants used to collect the blood samples. Plasma osteocalcin concentrations measured by enzyme immunoassay and radioimmunoassay are influenced by the nature of the anticoagulants used. The most significant difference between concentrations found in plasma and serum was seen with oxalate/fluoride anticoagulant, which reduced osteocalcin concentrations to 37.3% of serum values. This is probably related to increased hemolysis with this anticoagulant compared with osteocalcin concentrations in plasma prepared with other anticoagulants. Samples prepared with sodium citrate (0.105 mol/L) or lithium heparin gave values 92.4% and 83.6% of those obtained with matched serum samples. Osteocalcin concentrations were relatively stable in plasma and serum at -20 degrees C for two freeze/thaw cycles. In blood from 100 patients there was a good correlation between osteocalcin concentrations in serum and plasma (lithium heparin) (r2 = 0.831); the slope and intercept (+/- SE) were 0.924 +/- 0.04 and 4.92 +/- 1.25 micrograms/L, respectively. However, in 10 patients, serum osteocalcin concentrations were two- to threefold higher than those in matched plasma samples.

Search for Melanoma Markers in Plasma and Serum Samples

2005 ◽  
Vol 11 (3) ◽  
pp. 353-360 ◽  
Author(s):  
Roberta Seraglia ◽  
Susanna Vogliardi ◽  
Graziella Allegri ◽  
Stefano Comai ◽  
Mario Lise ◽  
...  
Keyword(s):  
High Frequency ◽  
Healthy Subjects ◽  
Ionic Species ◽  
Low Molecular Weight ◽  
Ionization Mass ◽  
Plasma Samples ◽  
Serum Samples ◽  
Blood Samples ◽  
Melanoma Patients ◽  
Diagnostic Ions

Fourteen blood samples from patients with melanomas and 11 blood samples from healthy subjects were analyzed by matrix-assisted laser desorption/ionization mass spectrometry. The study focussed on species of low molecular weight, in the 800–5000 Da range, present in plasma and sera. While for healthy subjects plasma samples lead to the production of a higher number of ionic species, for melanoma patients a high number of diagnostic ions, present with high frequency and with quite high relative abundance, are present, in particular, in serum samples and, to a lesser extent, also in plasma. Since plasma samples are obtained more easily in comparison to sera, it is possible to suggest that plasma can also be used for these studies.

scholarly journals Effects of storage temperature and repeated freeze–thaw cycles on stability of bovine plasma concentrations of haptoglobin and ceruloplasmin

2017 ◽  
Vol 29 (5) ◽  
pp. 738-740 ◽  
Author(s):  
Paulo G. M. A. Martins ◽  
Philipe Moriel ◽  
John D. Arthington
Keyword(s):  
Whole Blood ◽  
Storage Temperature ◽  
Plasma Concentrations ◽  
Freezing Temperature ◽  
Plasma Samples ◽  
Blood Samples ◽  
Freeze Thaw ◽  
Bovine Plasma ◽  
Whole Blood Samples ◽  
Freezing Temperatures

We evaluated the effects of storage temperature (−20 or −80°C) and handling procedure on plasma concentrations of bovine haptoglobin and ceruloplasmin. Within each temperature, whole blood samples were: centrifuged within 2 h of collection and plasma kept frozen until analysis (control); refrigerated at 4°C for 24 h before plasma harvest and freezing (24H); or plasma harvested and frozen within 2 h after collection, but then plasma samples were thawed and refrozen 1 wk (1X), 1 and 2 wk (2X), or 1, 2 and 3 wk (3X) before analyses. Haptoglobin concentrations were greatest at 24H, but similar among remaining treatments. Ceruloplasmin concentrations were not affected by the handling procedures. Storage temperature did not affect haptoglobin concentrations, but ceruloplasmin concentrations decreased when stored at −20 versus −80°C. Except for greater concentrations after 24 h storage at 4°C, haptoglobin concentrations remained stable at either freezing temperature and through freeze–thaw cycles. Ceruloplasmin concentrations decreased after 3 freeze–thaw cycles and required lower freezing temperatures to remain stable.

scholarly journals Double venipuncture is not required for adequate S-100B determination in melanoma patients

BioTechniques ◽  
2020 ◽  
Vol 69 (5) ◽  
pp. 371-378
Author(s):  
Samantha Damude ◽  
Anneke C Muller Kobold ◽  
Esther Bastiaannet ◽  
Schelto Kruijff ◽  
Harald J Hoekstra ◽  
...  
Keyword(s):  
Cancer Staging ◽  
Stage Iii ◽  
Tube System ◽  
Serum Samples ◽  
Blood Samples ◽  
Significant Difference ◽  
Melanoma Patients ◽  
The Mean ◽  
Stage Iii Melanoma

S-100B is used in melanoma follow-up. This serum biomarker is also present in adipocytes; therefore, subcutaneous adipocytes trapped in the needle before performing a venipuncture could contaminate the serum. The aim was to study the influence of adipocyte contamination on blood samples used for S-100B analysis, possibly resulting in falsely elevated S-100B values. A total of 294 serum samples were collected from 147 American Joint Committee on Cancer staging stage III melanoma patients. The mean difference between the first (dummy) and second tubes was 0.003 μg/l (p = 0.077), with a decrease in the second tube. Compared with the second tube, the S-100B level was higher in the first tube in 33.3% of the samples, equal in 36.8% of the samples and lower in 29.9% of the samples. No significant difference between the two consecutively drawn tubes was found. There seems to be no necessity of implementing a dummy tube system for accurate S-100B determination in melanoma patients.

Washing-free Chemiluminescence Immunoassay for Rapid Detection of cTnI in Whole Blood Samples

2021 ◽  
Author(s):  
Huan Zhao ◽  
Enben Su ◽  
Li Huang ◽  
Yunfeng Zai ◽  
Yuan Liu ◽  
...  
Keyword(s):  
Whole Blood ◽  
Rapid Detection ◽  
Magnetic Particles ◽  
Troponin I ◽  
Sample Type ◽  
Serum Samples ◽  
Chemiluminescence Immunoassay ◽  
Blood Samples ◽  
Significant Difference ◽  
Whole Blood Samples

Abstract Background: Chemiluminescence immunoassay (CLIA) has always been a great challenge in detecting whole blood samples without centrifugation because of the interference of red blood cells and low sensitivity. Results: In this scheme, the antigens and erythrocytes in the blood were captured by the antibodies immobilized on the magnetic particles, recognized by another biotin-conjugated cTnI antibody and detected by streptavidin/acridine aster-conjugated PCMS. After magnetic separation, the supernatant was transferred and measured. No significant difference was noted between the cTnI concentrations of the serum samples, plasma samples and whole blood. The prepared PCMS provided more functional areas to conjugate streptavidin and acridinium ester, so the immunoassay has highly sensitive, the limits of blank at 0.012 ng/mL, and functional sensitivity at 0.019 ng/mL with a CV of 20%, and 0.058 ng/mL with a CV of 10%. Total precision of any sample type ranged from 2.62~5.67%. The assay was linear over the studied range of 0.01–50.00 ng/mL, and no hook effect was found when cTnI concentrations reached 1900 ng/mL. No significant interference was noted with the potential endogenous interfering substances. Compared with the commercial kit (Abbott assay kit), the correlation coefficient was 0.9859.Conclusions: A washing-free chemiluminescence immunoassay (CLIA) was established for the rapid detection of cardiac troponin I (cTnI) in human whole blood, using erythrocyte capture antibodies-conjugated magnetic nanoparticles for eliminating the influence of erythrocytes and polychloromethylstyrene microspheres (PCMS) for signal amplification, which showed great potential in clinical application.

Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I

2018 ◽  
Vol 56 (3) ◽  
pp. 492-501 ◽  
Author(s):  
Silvia Masotti ◽  
Concetta Prontera ◽  
Veronica Musetti ◽  
Simona Storti ◽  
Rudina Ndreu ◽  
...  
Keyword(s):  
Cardiac Troponin ◽  
Troponin I ◽  
High Sensitivity ◽  
Cardiac Troponin I ◽  
Analytical Performance ◽  
Analytical Sensitivity ◽  
Plasma Samples ◽  
Serum Samples ◽  
Significant Difference ◽  
Heparin Plasma

AbstractBackground:The study aim was to evaluate and compare the analytical performance of the new chemiluminescent immunoassay for cardiac troponin I (cTnI), called Access hs-TnI using DxI platform, with those of Access AccuTnI+3 method, and high-sensitivity (hs) cTnI method for ARCHITECT platform.Methods:The limits of blank (LoB), detection (LoD) and quantitation (LoQ) at 10% and 20% CV were evaluated according to international standardized protocols. For the evaluation of analytical performance and comparison of cTnI results, both heparinized plasma samples, collected from healthy subjects and patients with cardiac diseases, and quality control samples distributed in external quality assessment programs were used.Results:LoB, LoD and LoQ at 20% and 10% CV values of the Access hs-cTnI method were 0.6, 1.3, 2.1 and 5.3 ng/L, respectively. Access hs-cTnI method showed analytical performance significantly better than that of Access AccuTnI+3 method and similar results to those of hs ARCHITECT cTnI method. Moreover, the cTnI concentrations measured with Access hs-cTnI method showed close linear regressions with both Access AccuTnI+3 and ARCHITECT hs-cTnI methods, although there were systematic differences between these methods. There was no difference between cTnI values measured by Access hs-cTnI in heparinized plasma and serum samples, whereas there was a significant difference between cTnI values, respectively measured in EDTA and heparin plasma samples.Conclusions:Access hs-cTnI has analytical sensitivity parameters significantly improved compared to Access AccuTnI+3 method and is similar to those of the high-sensitivity method using ARCHITECT platform.

scholarly journals First molecular evidence of Hepatozoon canis infection in Rhipicephalus sanguineus (sensu lato) ticks in Iran

2020 ◽  
Author(s):  
MohammadReza Zeinali ◽  
Farnaz Malekifard ◽  
Alaleh Rakhshanpour ◽  
Mohammad Yakhchali
Keyword(s):  
Rhipicephalus Sanguineus ◽  
Diagnostic Methods ◽  
Ixodid Ticks ◽  
Hepatozoon Canis ◽  
Molecular Evidence ◽  
Microscopical Examination ◽  
Serum Samples ◽  
Blood Samples ◽  
Significant Difference ◽  
Rhipicephalus Sanguineus Sensu Lato

Abstract Background Hepatozoon canis is a protozoan that is transmitted by the ixodid ticks. Ingesting the tick or a section of the tick organ which is infected by the mature oocysts containing infectious sporozoite is the main source of infection in dogs. Canine hepatozoonosis infects dogs in Iran, but the vector for Hepatozoon protozoa from Iran has never been demonstrated. The present study aims to detect H. canis in dogs and vector ticks in Iran. Methods During the period of 2018–2019, Blood samples and ixodid ticks were collected and examined using microscopical, molecular, and serological methods. A total of 246 blood samples were collected from the cephalic vein of pet, stray, and shelter dogs (103 stray, 99 shelter, and 44 pets) of both genders and varying ages in Northwest of Iran. Results Microscopically, infected neutrophils with Hepatozoon spp. were detected in 5 of 246 (2.03%) thin stained blood smears with low parasitemia. Indirect immunofluorescent antibody test (IFAT) was used to test the serum samples and antibodies against H. canis were detected in 31 (12.6%) of the serum samples. Molecularly, 23 out of 246 (9.34%) blood samples were found to be infected with H. canis. A comparison of the results of 3 diagnostic methods demonstrated a good agreement between IFAT and PCR and a poor agreement between microscopical examination with IFAT and PCR. There was no significant difference in different age groups and sex of sampled dogs. However, stray dogs had significant infection rate of than pets and shelter ones. In body inspection, 141 adult ticks (31 partially engorged females, 26 fully engorged female and 84 fed males) were collected from examined dogs and all ticks were belonging to species of Rhipicephalus sanguineus (sensu lato). Positive reaction to H. canis was observed in the genomic DNA of the 7 ticks (4.96%). A BLAST analysis of obtaining sequences isolated from both dogs and ticks indicated a 99–100% similarity with H. canis 18S rRNA gene sequences in GenBank. This is the first study in Iran to detect H. canis in R. sanguineus tick.

scholarly journals Metabolomics Approach for Validation of Self-Reported Ibuprofen and Acetaminophen Use

Metabolites ◽  
2018 ◽  
Vol 8 (4) ◽  
pp. 55
Author(s):  
Kristine Dennis ◽  
Brian Carter ◽  
Susan Gapstur ◽  
Victoria Stevens
Keyword(s):  
Mass Spectrometry ◽  
Self Report ◽  
Untargeted Metabolomics ◽  
Plasma Samples ◽  
Serum Samples ◽  
Over The Counter ◽  
Blood Samples ◽  
Cutoff Value ◽  
Analgesic Use ◽  
Metabolomics Analysis

Over-the-counter analgesic use is common and is typically assessed through self-report; therefore, it is subject to misclassification. Detection of drug metabolites in biofluids offers a viable tool for validating self-reported analgesic use. Thus, the aim of this study was to determine the utility of a metabolomics approach for the validation of acetaminophen and ibuprofen use in blood samples. Untargeted mass spectrometry-based metabolomics analysis was conducted in serum samples from 1547 women and plasma samples from 556 men. The presence of two metabolites each for acetaminophen and ibuprofen at levels at or above a defined cutoff value was used to determine concordance with self-reported use. For acetaminophen use based on the presence of both acetaminophen and acetamidophenylglucuronide, concordance was 98.5–100% among individuals reporting use today, and 79.8–91.4% for those reporting never or rare use. Ibuprofen use based on the presence of both carboxyibuprofen and hydroxyibuprofen resulted in concordance of 51.3–52.5% for individuals reporting use today and 99.4–100% for those reporting never or rare use. Our findings suggest that an untargeted metabolomics approach in blood samples may be useful for validating self-reported acetaminophen use. However, this approach appears unlikely to be suitable for validating ibuprofen use.

scholarly journals Aglutininas anti- Leptospira spp. em equídeos da região sul do Brasil abatidos em matadouro-frigorífico

2016 ◽  
Vol 37 (2) ◽  
pp. 841
Author(s):  
Renata Ferreira dos Santos ◽  
Glaucenyra Cecília Pinheiro da Silva ◽  
Nivaldo Aparecido de Assis ◽  
Luis Antonio Mathias
Keyword(s):  
Agglutination Test ◽  
High Rate ◽  
Rio Grande Do Sul ◽  
Serum Samples ◽  
Blood Samples ◽  
Federal Food ◽  
Significant Difference ◽  
Leptospira Spp ◽  
Males And Females ◽  
Inspection Service

The objective of this study was to investigate the presence of anti-Leptospira spp. antibodies in serum samples of horses slaughtered in an abattoir, under the Brazilian federal food inspection service, in the southern region of Brazil. We tested 767 blood samples from adult horses slaughtered from April to May, 2013. The animals came from 45 municipalities in the states of Rio Grande do Sul, Santa Catarina, and Paraná. For the diagnosis we used the microscopic agglutination test (MAT). The results showed that 687 horses reacted to at least one of the 24 serovars of Leptospira spp., with titer equal to or greater than 100, representing 89.57% (95% CI: 87.41%–91.73%). The most likely serovars were Patoc (9.91%), Butembo (9.13%), Australis (7.82%), and Bratislava (5.87%). There was no significant difference (p = 0.2795) in the number of positive animals by state. The proportion of MAT-positive males and females differed significantly (p = 5.4444 x 10-5) since 85.26% (95% CI: 82.82%–88.70%) of the males and 94.44 (95% CI: 92.07%–96.81%) of the females were reactive. The results of this study demonstrate a high rate exposure to several serovars of Leptospira in slaughtered horses. For the protection of animal, public, and occupational health, we suggest attention to infections in this host in order to reduce the risk of leptospirosis.

scholarly journals PSIV-25 Effect of Various Handling Methods of Plasma and Serum Samples on Pregnancy Associated Glycoprotein Concentrations

2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 289-290
Author(s):  
Grace M Wesson ◽  
Lohana Fernandez ◽  
Rebecca K Poole ◽  
Gessica A Franco ◽  
Sydney T Reese ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Plasma Samples ◽  
Freezing And Thawing ◽  
Serum Samples ◽  
Freeze Thaw ◽  
Thaw Cycle ◽  
Freeze Thaw Cycle ◽  
Repeated Freezing ◽  
Pregnancy Status ◽  
Handling Methods

Abstract Pregnancy associated glycoproteins (PAG) can be used as a biomarker for early pregnancy diagnosis, so accurate and consistent PAG detection is critical. The objective of this study was to determine if plasma and serum PAG concentrations were altered when centrifugation occurred at different times post-collection, when subjected to repeated freezing and thawing, and when monoclonal antibodies were kept in frequently or infrequently opened containers. Plasma (n = 4) and serum (n = 4) samples were collected from two open cows and two pregnant cows 28 days after artificial insemination. Pregnancy status was determined via transrectal ultrasonography. Plasma and serum samples were evenly separated and either centrifuged on the day of collection, or placed at 4°C and centrifuged the next day. An in-house PAG ELISA was performed on all samples before freezing (NOTHAW), after being frozen for one week (INTACT), after one freeze/thaw cycle (THAW1), two freeze/thaw cycles (THAW2), and three freeze/thaw cycles (THAW3). Data were analyzed using one-way ANOVA (GLM procedure, SAS 9.4). All samples from open cows were below the baseline of the assay. For pregnant cows, plasma samples had greater PAG concentrations than serum samples (11.84 vs 3.30 ± 0.66 ng/mL, respectively, P < 0.05). No differences were observed for day of centrifugation in both plasma and serum samples (P = 0.50 and P = 0.60, respectively) and in handling of monoclonal antibodies (P = 0.90). Freezing and thawing did not impact PAG concentrations in plasma samples (P = 0.19), but did alter serum concentrations (P = 0.01). Specifically, THAW1 (1.98 ng/mL) and THAW2 (1.42 ng/mL) serum PAG concentrations were lower compared to NOTHAW, THAW3, and INTACT samples (4.66, 4.85, and 3.57 ng/mL, respectively). Based on these data, plasma yields more consistent results than serum, even after several freeze-thaw cycles, and handling of monoclonal antibodies or time of centrifugation has no significant effect on measured PAG.

Results for serum and plasma compared in 15 selected radioassays.

1978 ◽  
Vol 24 (1) ◽  
pp. 137-139 ◽  
Author(s):  
N P Kubasik ◽  
H E Sine
Keyword(s):  
Plasma Samples ◽  
Serum Samples ◽  
Blood Samples ◽  
Clinical Interpretation ◽  
Sufficient Magnitude

Abstract We evaluated the results for serum vs. plasma samples for 15 selected radioassay procedures, using 19 manufacturers' kits. Blood samples were collected with heparin, oxalate-fluoride, or ethylenediaminetetraacetate anticoagulants and compared with serum samples. Differences were demonstrated between serum and plasma which may be of sufficient magnitude to alter clinical interpretation of the results. Assays also demonstrated significant differences based on the kit manufacturer and procedure used.

Sign in / Sign up

Export Citation Format

Share Document